Different tau fibril types reduce prion level in chronically and de novo infected cells.
Ontology highlight
ABSTRACT: Neurodegenerative diseases are often characterized by the codeposition of different amyloidogenic proteins, normally defining distinct proteinopathies. An example is represented by prion diseases, where the classical deposition of the aberrant conformational isoform of the prion protein (PrPSc) can be associated with tau insoluble species, which are usually involved in another class of diseases called tauopathies. How this copresence of amyloidogenic proteins can influence the progression of prion diseases is still a matter of debate. Recently, the cellular form of the prion protein, PrPC, has been investigated as a possible receptor of amyloidogenic proteins, since its binding activity with Aβ, tau, and α-synuclein has been reported, and it has been linked to several
SUBMITTER: Celauro L
PROVIDER: S-EPMC10432985 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA